Completed PHASE4 INTERVENTIONAL NCT00941096

Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination

Efficacy Of The Bimatoprost/Timolol Fixed Combination In Patients Treated With Bimatoprost for Primary Open Angle Glaucoma, Exfoliation Glaucoma or Ocular Hypertension.

Sponsor: Larissa University Hospital

Conditions Glaucoma Ocular Hypertension

Interventions Bimatoprost and Bimatoprost/Timolol fixed combination.

Updated 5 times since 2017 Last updated: Nov 29, 2010 Started: Jul 31, 2009 Primary completion: Nov 30, 2010 Completion: Nov 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00941096, this PHASE4 trial focuses on Glaucoma and Ocular Hypertension and remains completed. Sponsored by Larissa University Hospital, it has been updated 5 times since 2009, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Larissa University Hospital

Data source: Larissa University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Larissa, Greece